{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T11:05:07Z","timestamp":1779966307233,"version":"3.53.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12328-026-02306-3","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:37:39Z","timestamp":1774269459000},"page":"639-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-cirrhotic portal\u2013splenic\u2013mesenteric vein thrombosis unmasking JAK2 V617F-positive polycythemia vera"],"prefix":"10.1007","volume":"19","author":[{"given":"Tomoki","family":"Otake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3842-1703","authenticated-orcid":false,"given":"Masamichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminori","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"2306_CR1","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3390\/ijms24032262","volume":"24","author":"S Camerlo","year":"2023","unstructured":"Camerlo S, Ligato J, Rosati G, et al. Shedding light on the pathogenesis of splanchnic vein thrombosis. Int J Mol Sci. 2023;24:2262.","journal-title":"Int J Mol Sci"},{"key":"2306_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/ajh.25677","volume":"95","author":"E Sant\u2019Antonio","year":"2020","unstructured":"Sant\u2019Antonio E, Guglielmelli P, Pieri L, et al. Splanchnic vein thromboses associated with myeloproliferative neoplasms: an international, retrospective study on 518 cases. Am J Hematol. 2020;95:156\u201366.","journal-title":"Am J Hematol"},{"key":"2306_CR3","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1182\/bloodadvances.2020002414","volume":"4","author":"PE Debureaux","year":"2020","unstructured":"Debureaux PE, Cassinat B, Soret-Dulphy J, et al. Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses. Blood Adv. 2020;4:3708\u201315.","journal-title":"Blood Adv"},{"key":"2306_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/ejh.13335","volume":"104","author":"D Tremblay","year":"2020","unstructured":"Tremblay D, Vogel AS, Moshier E, et al. Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience. Eur J Haematol. 2020;104:72\u20133.","journal-title":"Eur J Haematol"},{"key":"2306_CR5","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/ajh.27002","volume":"98","author":"A Tefferi","year":"2023","unstructured":"Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023;98:1465\u201387.","journal-title":"Am J Hematol"},{"key":"2306_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.thromres.2022.08.003","volume":"218","author":"D Tremblay","year":"2022","unstructured":"Tremblay D, Winters A, Beckman JD, et al. Splanchnic vein thrombosis associated with myeloproliferative neoplasms. Thromb Res. 2022;218:8\u201316.","journal-title":"Thromb Res"},{"key":"2306_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17474086.2025.2570337","volume":"19","author":"ZA Durak","year":"2025","unstructured":"Durak ZA, Demirci Z, E\u015fkazan AE. Masked polycythemia vera: diagnostic challenges and clinical implications. Expert Rev Hematol. 2025;19:1\u20133.","journal-title":"Expert Rev Hematol"},{"key":"2306_CR8","doi-asserted-by":"publisher","first-page":"4921","DOI":"10.1182\/blood-2011-09-376517","volume":"120","author":"JH Smalberg","year":"2012","unstructured":"Smalberg JH, Arends LR, Valla DC, et al. Myeloproliferative neoplasms in Budd\u2013Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012;120:4921\u20138.","journal-title":"Blood"},{"key":"2306_CR9","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","volume":"122","author":"T Barbui","year":"2013","unstructured":"Barbui T, Finazzi G, Falanga A. Myeloproliferative neoplasms and thrombosis. Blood. 2013;122:2176\u201384.","journal-title":"Blood"},{"key":"2306_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/2040620716680333","volume":"8","author":"J How","year":"2017","unstructured":"How J, Zhou A, Oh ST. Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease. Ther Adv Hematol. 2017;8:107\u201318.","journal-title":"Ther Adv Hematol"},{"key":"2306_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1182\/blood.2020006827","volume":"137","author":"E Valeriani","year":"2021","unstructured":"Valeriani E, Di Nisio M, Riva N, et al. Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis. Blood. 2021;137:1233\u201340.","journal-title":"Blood"},{"key":"2306_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1182\/bloodadvances.2019001310","volume":"4","author":"L Naymagon","year":"2020","unstructured":"Naymagon L, Tremblay D, Zubizarreta N, et al. The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis. Blood Adv. 2020;4:655\u201366.","journal-title":"Blood Adv"},{"key":"2306_CR13","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s11239-020-02052-4","volume":"50","author":"L Naymagon","year":"2020","unstructured":"Naymagon L, Tremblay D, Zubizarreta N, et al. Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation. J Thromb Thrombolysis. 2020;50:652\u201360.","journal-title":"J Thromb Thrombolysis"},{"key":"2306_CR14","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1111\/j.1538-7836.2011.04484.x","volume":"9","author":"J Hoekstra","year":"2011","unstructured":"Hoekstra J, Bresser EL, Smalberg JH, et al. Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms. J Thromb Haemost. 2011;9:2208\u201314.","journal-title":"J Thromb Haemost"},{"key":"2306_CR15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41408-018-0100-9","volume":"8","author":"G Finazzi","year":"2018","unstructured":"Finazzi G, De Stefano V, Barbui T. Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment algorithm 2018. Blood Cancer J. 2018;8:64.","journal-title":"Blood Cancer J"},{"key":"2306_CR16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/ajh.26896","volume":"98","author":"JJ Kiladjian","year":"2023","unstructured":"Kiladjian JJ, Cassinat B. Myeloproliferative neoplasms and splanchnic vein thrombosis: contemporary diagnostic and therapeutic strategies. Am J Hematol. 2023;98:794\u2013800.","journal-title":"Am J Hematol"},{"key":"2306_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/cancers15010011","volume":"15","author":"A Liu","year":"2022","unstructured":"Liu A, Naymagon L, Tremblay D. Splanchnic vein thrombosis in myeloproliferative neoplasms: treatment considerations and unmet needs. Cancers (Basel). 2022;15:11.","journal-title":"Cancers (Basel)"},{"key":"2306_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","volume":"64","author":"European Association for the Study of the Liver","year":"2016","unstructured":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Vascular diseases of the liver. J Hepatol. 2016;64:179\u2013202.","journal-title":"J Hepatol"},{"key":"2306_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/hep.31646","volume":"73","author":"PG Northup","year":"2021","unstructured":"Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;73:366\u2013413.","journal-title":"Hepatology"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02306-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02306-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:22:36Z","timestamp":1779963756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02306-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2306"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02306-3","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordancewith the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights statement"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}